Surgery Partners (NASDAQ:SGRY – Get Free Report) had its price target reduced by analysts at Macquarie from $34.00 to $33.00 in a research report issued on Tuesday,Benzinga reports. The firm currently ...
NEW YORK--(BUSINESS WIRE)--Today, Macquarie Asset Management expanded its active exchange-traded fund (ETF) platform with the launch of Macquarie National High-Yield Municipal Bond ETF (HTAX).